Cresset Asset Management, LLC - PROGENICS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Cresset Asset Management, LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$0640.0%0.00%
Q4 2018$0640.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 6,158,000$38,611,0002.32%
ARDSLEY ADVISORY PARTNERS LP 2,045,000$12,822,0001.73%
RA Capital Management 3,030,303$19,000,0001.02%
Phocas Financial Corp. 1,736,386$10,887,0000.95%
ARDSLEY ADVISORY PARTNERS LP 500,000$3,135,0000.42%
RICE HALL JAMES & ASSOCIATES, LLC 1,345,260$8,435,0000.30%
BKS ADVISORS, LLC 115,115$721,0000.26%
PINNACLE ASSOCIATES LTD 1,530,657$9,597,0000.20%
CARILLON TOWER ADVISERS, INC. 3,948,024$24,745,0000.18%
EAGLE ASSET MANAGEMENT INC 4,444,673$27,868,0000.14%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders